Glenn; Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glenn; Joseph.The latest application filed is for "tricyclic fused thiophene derivatives as jak inhibitors".

Company Profile

10.31.39

Glenn; Joseph - Mount Royal NJ
Glenn; Joseph - Sicklerville NJ US
Glenn; Joseph - Eden Prairie MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclylamines as PI3K inhibitors Grant 11,433,071 - Li , et al. September 6, 2	2022-09-06
Tricyclic Fused Thiophene Derivatives As Jak Inhibitors App 20210387998 - Li; Yun-Long ; et al.	2021-12-16
Tricyclic fused thiophene derivatives as JAK inhibitors Grant 11,161,855 - Li , et al. November 2, 2	2021-11-02
Pyrrolopyrimidine derivatives as TAM inhibitors Grant 11,136,326 - Li , et al. October 5, 2	2021-10-05
Pyrrolotriazine Compounds As Tam Inhibitors App 20210147430 - Li; Yun-Long ; et al.	2021-05-20
Heterocyclylamines As Pi3k Inhibitors App 20200323858 - Li; Yun-Long ; et al.	2020-10-15
Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20200181151 - Li; Yun-Long ; et al.	2020-06-11
Heterocyclylamines as PI3K inhibitors Grant 10,646,492 - Li , et al.	2020-05-12
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors Grant 10,640,506 - Rodgers , et al.	2020-05-05
Tricyclic Fused Thiophene Derivatives As Jak Inhibitors App 20200040002 - Li; Yun-Long ; et al.	2020-02-06
Pyrrolopyrimidine derivatives as TAM inhibitors Grant 10,519,163 - Li , et al. Dec	2019-12-31
Cyclobutyl Substituted Pyrrolopyridine And Pyrrolopyrimidines Derivatives As Jak Inhibitors App 20190135813 - Rodgers; James D. ; et al.	2019-05-09
Heterocyclylamines As Pi3k Inhibitors App 20190134040 - Li; Yun-Long ; et al.	2019-05-09
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20190040067 - Li; Yun-Long ; et al.	2019-02-07
Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20190031663 - Li; Yun-Long ; et al.	2019-01-31
Pyrrolotriazine Compounds As Tam Inhibitors App 20180327412 - Li; Yun-Long ; et al.	2018-11-15
Heterocyclylamines as PI3K inhibitors Grant 10,092,570 - Li , et al. October 9, 2	2018-10-09
Pyrrolopyrimidine derivatives as TAM inhibitors Grant 10,053,465 - Li , et al. August 21, 2	2018-08-21
Tricyclic Fused Thiophene Derivatives As Jak Inhibitors App 20180148460 - Li; Yun-Long ; et al.	2018-05-31
Tricyclic fused thiophene derivatives as JAK inhibitors Grant 9,908,895 - Li , et al. March 6, 2	2018-03-06
Heterocyclylamines As Pi3k Inhibitors App 20170340641 - Li; Yun-Long ; et al.	2017-11-30
Pyrrolotriazine Compounds As Tam Inhibitors App 20170275290 - Li; Yun-Long ; et al.	2017-09-28
Heterocyclylamines as PI3K inhibitors Grant 9,730,939 - Li , et al. August 15, 2	2017-08-15
Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20170057965 - Li; Yun-Long ; et al.	2017-03-02
Bicyclic Fused Pyrimidine Compounds As Tam Inhibitors App 20170044164 - Li; Yun-Long ; et al.	2017-02-16
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors Grant 9,334,274 - Rodgers , et al. May 10, 2	2016-05-10
Heterocyclylamines As Pi3k Inhibitors App 20160024117 - Li; Yun-Long ; et al.	2016-01-28
Tricyclic Fused Thiophene Derivatives As Jak Inhibitors App 20160024109 - Li; Yun-Long ; et al.	2016-01-28
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors Grant 9,193,733 - Rodgers , et al. November 24, 2	2015-11-24
Piperazinylpiperidine derivatives as chemokine receptor antagonists Grant 9,067,921 - Xue , et al. June 30, 2	2015-06-30
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors Grant 9,034,884 - Rodgers , et al. May 19, 2	2015-05-19
Cyclobutyl Substituted Pyrrolopyridine And Pyrrolopyrimidines Derivatives As Jak Inhibitors App 20150087632 - Rodgers; James D. ; et al.	2015-03-26
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors Grant 8,933,085 - Rodgers , et al. January 13, 2	2015-01-13
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20140249132 - Li; Yun-Long ; et al.	2014-09-04
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20140221379 - Rodgers; James D ; et al.	2014-08-07
Piperazinylpiperidine Derivatives As Chemokine Receptor Antagonists App 20140155404 - Xue; Chu-Biao ; et al.	2014-06-05
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors Grant 8,716,303 - Rodgers , et al. May 6, 2	2014-05-06
Tricyclic Fused Thiophene Derivatives As Jak Inhibitors App 20140121198 - Li; Yun-Long ; et al.	2014-05-01
Piperazinylpiperidine derivatives as chemokine receptor antagonists Grant 8,680,104 - Xue , et al. March 25, 2	2014-03-25
Piperidinylcyclobutyl Substituted Pyrrolopyridine And Pyrrolopyrimidine Derivatives As Jak Inhibitors App 20140005166 - RODGERS; JAMES D. ; et al.	2014-01-02
3-aminocyclopentanecarboxamides as modulators of chemokine receptors Grant 8,563,582 - Xue , et al. October 22, 2	2013-10-22
3-aminocyclopentanecarboxamides as modulators of chemokine receptors Grant 8,470,827 - Xue , et al. June 25, 2	2013-06-25
Heterocyclylamines As Pi3k Inhibitors App 20130059835 - Li; Yun-Long ; et al.	2013-03-07
Piperazinylpiperidine Derivatives As Chemokine Receptor Antagonists App 20120295912 - Xue; Chu-Biao ; et al.	2012-11-22
Piperazinylpiperidine derivatives as chemokine receptor antagonists Grant 8,268,826 - Xue , et al. September 18, 2	2012-09-18
Cyclobutyl Substituted Pyrrolopyridine And Pyrrolopyrimidine Derivatives As Jak Inhibitors App 20120149681 - RODGERS; JAMES D. ; et al.	2012-06-14
Heterocyclic-substituted Pyrrolopyridines And Pyrrolopyrimidines As Jak Inhibitors App 20120149682 - Rodgers; James D. ; et al.	2012-06-14
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20100298334 - Rodgers; James D. ; et al.	2010-11-25
Programmable memory cell Grant 7,796,418 - Schmitt , et al. September 14, 2	2010-09-14
3-aminocyclopentanecarboxamides As Modulators Of Chemokine Receptors App 20100119503 - Xue; Chu-Biao ; et al.	2010-05-13
Piperazinylpiperidine derivatives as chemokine receptor antagonists Grant 7,678,798 - Xue , et al. March 16, 2	2010-03-16
3-aminocyclopentanecarboxamides as modulators of chemokine receptors Grant 7,618,970 - Xue , et al. November 17, 2	2009-11-17
Programmable memory cell App 20090237974 - Schmitt; Jonathan ; et al.	2009-09-24
3-aminocyclopentanecarboxamides As Modulators Of Chemokine Receptors App 20090208485 - Xue; Chu-Biao ; et al.	2009-08-20
Piperazinylpiperidine Derivatives As Chemokine Receptor Antagonists App 20090197887 - XUE; Chu-Biao ; et al.	2009-08-06
3-aminocyclopentanecarboxamides as modulators of chemokine receptors Grant 7,449,467 - Xue , et al. November 11, 2	2008-11-11
3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors Grant 7,307,086 - Xue , et al. December 11, 2	2007-12-11
Salts of N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohex- yl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide App 20060111404 - Xue; Chu-Biao ; et al.	2006-05-25
3-aminocyclopentanecarboxamides as modulators of chemokine receptors App 20060020133 - Xue; Chu-Biao ; et al.	2006-01-26
3-Aminocyclopentanecarboxamides as modulators of chemokine receptors App 20060004018 - Xue; Chu-Biao ; et al.	2006-01-05
3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors App 20050267146 - Xue, Chu-Biao ; et al.	2005-12-01
Piperazinylpiperidine derivatives as chemokine receptor antagonists App 20050261310 - Xue, Chu-Biao ; et al.	2005-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.